Also, in T2DM patients, ASL-MRI and BOLD-MRI showed improved cortical and medullary oxygenation after 24-weeks SGLT2 inhibition, without a change in RP (Zhou et al., 2021). The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.